oxprenolol has been researched along with Stammering in 1 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a controlled trial of treatment for stammering under stress oxprenolol (40 mg) compared with placebo was assessed in a double-blind manner over two days, six weeks apart, in 31 stammerers before and after speech therapy." | 9.05 | Controlled trial of speech therapy versus oxprenolol for stammering. ( Cook, PJ; James, IM; Kuhr, A; Rustin, L, 1981) |
| "In a controlled trial of treatment for stammering under stress oxprenolol (40 mg) compared with placebo was assessed in a double-blind manner over two days, six weeks apart, in 31 stammerers before and after speech therapy." | 5.05 | Controlled trial of speech therapy versus oxprenolol for stammering. ( Cook, PJ; James, IM; Kuhr, A; Rustin, L, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rustin, L | 1 |
| Kuhr, A | 1 |
| Cook, PJ | 1 |
| James, IM | 1 |
1 trial available for oxprenolol and Stammering
| Article | Year |
|---|---|
Controlled trial of speech therapy versus oxprenolol for stammering.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ma | 1981 |